Rantizo income statement
In fiscal 2025, Rantizo reported revenue of $12.9m, up 16.6% on the year before, operating income of −$2.5m (a -19.6% margin) and net income of −$2.9m, or −$0.16 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|
| Revenue | 10 | 10 | 11 | 13 |
| Cost of revenue | 5 | 7 | 7 | 10 |
| Gross profit | 5 | 3 | 4 | 3 |
| General and administrative | 3 | 2 | 3 | 3 |
| Operating income | 2 | 0 | 1 | −3 |
| Interest expense | 0 | 0 | 0 | 0 |
| Income before tax | 2 | 0 | 1 | −3 |
| Income tax | 0 | 0 | 0 | 0 |
| Net income | 1 | 0 | 0 | −3 |
| Diluted EPS | $0.10 | $0.01 | $0.02 | −$0.16 |
| Diluted shares (average) | 14m | 14m | 16m | 19m |
| EBITDA | 3 | 2 | 2 | −1 |
Compare with peers
- Where Food Comes From, Inc. income statement
- Farmmi, Inc. income statement
- Immucell Corp income statement
- Arcadia Biosciences, Inc. income statement
- Cibus, Inc. income statement
Head to head: RNTZ vs WFCFFAMI vs RNTZICCC vs RNTZ
More: Agricultural Products & Services stocks compared, Consumer Staples sector, rankings of US companies